Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

ClinicalTrials.gov ID: NCT01644669

Public ClinicalTrials.gov record NCT01644669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx® System® at the Time of Breast Conservation Surgery for Early Stage Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to assess the safety and efficacy of the Xoft Axxent eBx System when used for single-fraction IORT in early stage breast cancer. Hypothesis: IORT using the Xoft Axxent eBx System is no worse (non-inferior) than whole breast irradiation (WBI) when used as stand-alone radiation treatment in breast conserving therapy in women with early stage breast cancer.

Study identification

NCT ID
NCT01644669
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Xoft, Inc.
Industry
Enrollment
1,200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2012 (Actual)
Primary completion
Jul 12, 2023 (Actual)
Completion
Dec 31, 2029 (Estimated)
Last update posted
Jan 31, 2025

2012 – 2029

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85704 —
City of Hope Duarte California 91010 —
Long Beach Memorial Medical Center Long Beach California 90806 —
UCLA Los Angeles California 90095 —
Tri-City Medical Center Oceanside California 92056 —
Diablo Valley Oncology Hematology Medical Group Pleasant Hill California 94523 —
Western Surgical Care, PC Denver Colorado 80220 —
Swedish Medical Center Englewood Colorado 80113 —
Florida Hospital Celebration Health Celebration Florida 34747 —
Doctors Hospital Coral Gables Florida 33146 —
Martin Health System Center for Clinical Research Stuart Florida 34994 —
Rush University Chicago Illinois 60612 —
Lutheran Hospital of Indiana Fort Wayne Indiana 46804 —
Greater Baltimore Medical Center Baltimore Maryland 21204 —
MedStar Oncology Network - Good Samaritan Hospital Baltimore Maryland 21218 —
MedStar Oncology Network - Franklin Square Baltimore Maryland 21237 —
Exeter Hospital Exeter New Hampshire 03833 —
Staten Island University Hospital Staten Island New York 10305 —
University of Oklahoma Oklahoma City Oklahoma 73104 —
Parkridge Medical Center Chattanooga Tennessee 37404 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37212 —
Sentara Northern Virginia Medical Center Woodbridge Virginia 22191 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01644669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01644669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →